BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

BIOFLAG-VitafoodsEU25

More Like This

PR Newswire associated0

Biotic innovation tackles iron deficiency in women - now recognized across three continents

PR Newswire associated0

Glac Biotech Secures U.S. Food and Drug Administration GRAS Approval for Probiotic Strain CP-9

PR Newswire associated0

PROBIOS TO ACQUIRE 100 % OF BIOTOBIO

PR Newswire associated0

Angel Group's First Industrialized Strain of Probiotics Anchors Strategic Transformation Towards Biotechnology

PR Newswire associated0

Angel Yeast Expands into Probiotics R&D and Production, Advances Biotech Transformation

IFF Pharma Solutions to Showcase Plant-Based Dietary Supplement Ingredients and Technical Expertise at Vitafoods™ Europe 2025

Bifidobacterium infantis M-63 is a unique probiotic strain of human-residential bifidobacteria (HRB) – bifidobacteria that naturally reside in the human gut – and is renowned for its ability to utilize human milk oligosaccharides (HMO) found in breast milk, significantly improving the intestinal environment of healthy full-term infants. (Graphic: Business Wire)

Morinaga Milk Obtains the Registration of "New Food Ingredient" in China for use of its Probiotic Bifidobacterium infantis M-63 in Infant Foods

21st.BIO obtains self-affirmed GRAS status for its precision fermented beta-lactoglobulin: 21st.BIO customers can now enter the U.S. market with their own production using 21st.BIO technology